ClinicalTrials.Veeva

Menu

Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics

K

Kerckhoff Klinik

Status

Enrolling

Conditions

CTEPH

Study type

Observational

Funder types

Other

Identifiers

NCT07299227
AZ 158/24

Details and patient eligibility

About

Patients with CTEPH referred for evaluation and conduction of BPA undergo standard of care diagnostic tests and treatment. This includes conventional echocardiographic, RHC and non-invasive (CT/CMR) or invasive (coronary angiography) coronary artery disease work-up. BPA will be conducted in generally 5 to 6 consecutive sessions. CMR will be performed prior to first and following the last intervention. Patient recruitment will be performed within 3 years, that is the last BPA session of the last patient in will have been performed at 3 years time.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient referred to BPA
  • clinical indication for CMR
  • capability to give informed consent

Exclusion criteria

  • general: non-compliance, <18 years of age, pregnancy
  • contraindications for CMR (non-CMR compatible device, chronic kidney disease (eGFR <30ml/min), allergies (medications)

Trial design

60 participants in 1 patient group

CTEPH patient

Trial contacts and locations

1

Loading...

Central trial contact

Andreas Rolf, MD; Sören Jan Backhaus, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems